Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00589563 · OUTCOME

Cumulative Incidence of Chronic GVHD

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer · Source last updated 2014-09-10

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
Percentage of patients developing cGVHD
Interval / dispersion
95% Confidence Interval
Time frame
2 year point estimate was provided.

What was measured

Patients were evaluated for the development of chronic GVHD from 101 days post HSCT to last contact or documented evidence of the disease. The cumulative incidence of chronic GVHD was determined using competing risk analysis. Competing risks for GVHD were death and nonengraftment.

Groups in this outcome

All Patients

All patients were analyzed as a single population. Stratification by conditioning regimen was not done.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
All Patients32

Reported measurements

Source class 1
Values in Percentage of patients developing cGVHD · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
All Patients62.5Not reported47.881.7Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        47.8
        upper Limit
        81.7
        value
        62.5
denoms
  1. counts
    1. group Id
      OG000
      value
      32
    units
    Participants
description
Patients were evaluated for the development of chronic GVHD from 101 days post HSCT to last contact or documented evidence of the disease. The cumulative incidence of chronic GVHD was determined using competing risk analysis. Competing risks for GVHD were death and nonengraftment.
dispersion Type
95% Confidence Interval
groups
  1. description
    All patients were analyzed as a single population. Stratification by conditioning regimen was not done.
    id
    OG000
    title
    All Patients
param Type
NUMBER
reporting Status
POSTED
time Frame
2 year point estimate was provided.
title
Cumulative Incidence of Chronic GVHD
type
PRIMARY
unit Of Measure
Percentage of patients developing cGVHD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice